Artemether

Artemether API (CAS No: 71963-77-4) is a widely used antimalarial pharmaceutical compound belonging to the artemisinin derivative class. It plays a crucial role in the treatment of malaria, particularly in combination therapies designed to improve therapeutic effectiveness and reduce resistance.

This material is extensively utilized in the formulation of oral and injectable dosage forms, including tablets, capsules, and suspensions. Artemether is commonly used as a key component in Artemisinin-based Combination Therapies (ACTs), which are recommended globally for the treatment of uncomplicated malaria.

The product is supplied in compliance with internationally accepted pharmacopeial standards including USP, BP, EP, and IP (as applicable). It is handled under controlled conditions to ensure high purity, stability, and consistent performance across batches. Each supply is supported with complete documentation such as COA, MSDS, and other regulatory documents as required.

Artemether API is packaged in export-compliant HDPE drums to maintain product integrity during storage and transportation. Flexible packaging and shipment options are available based on client specifications and international logistics requirements.

The demand for Artemether remains strong across global markets, particularly in regions with high malaria prevalence such as Africa, Southeast Asia, and parts of Latin America. Reliable sourcing and consistent supply of this API are essential to support pharmaceutical manufacturing and public health programs worldwide.